| |
|
|
|
Corbus Pharmaceuticals Holdings Inc.  
|
|
1.87 -0.01 (-0.01%) |
03-05 16:00 |
|
Open: |
1.89 |
Pre close: |
1.88 |
Target:
|
3.61 
|
|
High: |
1.91 |
Low: |
1.63 |
Resistance:
|
3.09
4.00
|
|
Volume: |
8,329,326 |
Market Cap: |
157M |
Support:
|
1.63
1.36
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.14
|
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
2.65 |
Signal(12,26,9): |
0.09 |
|
MA(100): |
1.65  |
Stochastic Oscillator |
%K(14,3):
|
9.57 |
|
MA(250): |
4.24 |
%D(3): |
11.35 |
|
Average Volume(K) |
3-Month: |
1560680
|
52-Week |
High:
|
9.78 |
|
10-Days: |
1125889 |
Low: |
0.91 |
|
RSI |
RSI(14):
|
36.92 |
Change(%): |
-55.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.784 |
Return on Equity (ttm) |
-439.1 |
Shares Out. (M) |
84.04 |
|
EPS Est. Current Year |
-0.640 |
Return on Assets (ttm) |
-98.5 |
Shares Float (M) |
77.54 |
|
EPS Est. Next Year |
-0.680 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.73 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
-52.5 |
% Held by Institutions |
75.49 |
|
Forward EPS |
-1.120 |
Gross Profit (p.s.) |
-0.636 |
Shares Short (K) |
22140 |
|
Book Value (p.s.) |
0.360 |
EBITDA (p.s.) |
-1.524 |
P/E |
-1.05 |
|
Sales Per Share |
0.070 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.19 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-104.02 |
P/S |
26.86 |
|
Operating Margin |
-2207.39 |
Levered Free Cash Flow
(M) |
-58.40 |
P/CF |
-1.51 |
|
|
|
|
|
|
